SettleSignal
Settlements Data breachConsumer refundsPrivacy & biometrics How we verify Guides Help center For business Log in See what you may be owed →
BioXcel Therapeutics Settlement defendant
14 fields cited Claim window closed Proof needed

BioXcel Therapeutics $9.75M Class Action Settlement

Investors who purchased or otherwise acquired BioXcel Therapeutics Inc.

Investors who purchased or otherwise acquired BioXcel Therapeutics Inc. common stock between March 9, 2023, and June 28, 2023. Payout: Approximately $1.52 per share before deductions from a $9,750,000 settlement fund. Proof of purchase is required to file. Claim deadline: June 30, 2026. Checked against the official settlement source by SettleSignal on June 19, 2026.

This settlement is closed. The claim deadline was June 30, 2026. It’s listed here for reference — the claim window has closed. Browse settlements open for claims →

Who may qualify

You self-certify the basics when you file — the settlement administrator makes the final eligibility decision.

Investors who purchased or otherwise acquired BioXcel Therapeutics Inc. common stock between March 9, 2023, and June 28, 2023

This summary is based on available official settlement sources. The settlement administrator determines eligibility and payment approval.

New to the terms? Plain-English: claim deadline, proof of purchase, administrator, pro rata.

Proof requirements

Proof requirement is currently marked as Yes.

Review the official claim form before submitting any information.

Important dates

Jun 30, 2026
closed
Claim deadline (closed)
Last day to submit a claim to the administrator.
Aug 5, 2026
opt-out
Exclusion deadline
Last day to opt out of the settlement.
Aug 5, 2026
object
Objection deadline
Last day to file an objection with the court.

What you'll need to file

From our inspection of the official claim form:

  • Filing method Online or mail-in
  • Notice ID Not needed
  • Documentation Required to upload proof of transactions/holdings (broker trade confirmations and/or monthly brokerage statements). File upload is mandatory for online filing. Representative Filers must submit transactions in an electr…

How hard is this claim to file?

This is a securities class action settlement for investors who bought BioXcel Therapeutics common stock during the class period. There is no automatic payment — you must file a Proof of Claim and Release Form with supporting brokerage records before the claim deadline. This claim form asks for 6 fields and 3 documents.

What the form asks

  • — Your SSN (individuals) or EIN/TIN (entities) (Your tax documents or brokerage account records)
  • — Number of BioXcel common shares you held at the end of trading the day before the class period began (Brokerage account statement for March 8, 2023)
  • — Date of each buy or sell transaction during the class period (Broker confirmation slips or account statements)
  • — Share quantity for each individual transaction (Broker confirmation slip for each trade)
  • — Per-share price and total dollar value for each transaction (Broker confirmation slip for each trade)
  • — Number of BioXcel common shares you held at end of trading on the last day of the class period (Brokerage account statement for June 28, 2023)

Documents you'll need

Watch out for

  • All joint purchasers must sign the claim form — a missing co-owner signature can void the claim.
  • Executors, administrators, guardians, conservators, and trustees must attach proof of authority when filing on behalf of others.
  • Shares bought and sold entirely before June 29, 2023, have a recognized loss of zero and will generate no payout.
  • Class members whose calculated payment falls below a minimum threshold will not receive a payout.
  • Payout is pro rata and depends on the total number of valid claims submitted — actual recovery may be higher or lower than the estimated average.

We prepare — you file on the official site yourself. This is not legal advice and is not an eligibility decision; the administrator and court decide.

How do I file a claim for this settlement?

This record no longer has an open public claim form — confirm the current status and any next steps on the official source.

  1. 1
    Confirm you purchased or acquired BioXcel Therapeutics Inc. common stock (CUSIP 09075P204) between March 9, 2023, and June 28, 2023.
  2. 2
    Gather your brokerage records showing shares held as of the close of trading on March 8, 2023, all trade dates and prices through June 28, 2023, and shares held as of the close of trading on June 28, 2023.
  3. 3
    File your Proof of Claim and Release Form online at bioxcelsecuritiessettlement.com/file-a-claim/ or download, complete, and mail the PDF claim form to the settlement administrator before the claim deadline.
  4. 4
    If filing by mail, send to: Hills et al. v. BioXcel Therapeutics Inc., et al., c/o Strategic Claims Services, 600 N. Jackson St., Suite 205, P.O. Box 230, Media, PA 19063.
  5. 5
    If you are filing on behalf of another person (estate, trust, minor), include proof of your authority to act.

New to settlement claims? How to file safely →  ·  Worried it might be fake? Run the 60-second legitimacy check →

When will I get paid?

  1. Claims open You are here
  2. Court approval
  3. Payments sent
  4. Distribution complete

Claims are still being accepted. Class-action payouts typically begin only after the claim deadline, final court approval, and any appeals.

Verify it yourself

How we verified this record

Optional, but it's the whole point — every field below traces to a named official source we re-check on a schedule.

Verification in progress 7 / 8 fields checked
  • Claim deadline the official settlement website · Jun 19, 2026
  • Payout details the official settlement website · Jun 19, 2026
  • Eligibility the official settlement website · Jun 19, 2026
  • Proof requirement the official settlement website · Jun 19, 2026
  • Administrator the official settlement website · Jun 19, 2026
  • Official claim link the official settlement website · Jun 19, 2026
  • Payment status the official settlement website · Jun 19, 2026
  • Court case queued for re-check

Every published record clears our source-verification bar; remaining fields are checked one by one on our weekly re-verification pass.

Cross-checked against 1 official source on file.

Checked fields are matched against a named official source and re-checked on a schedule. We show the authority and the date, never our internal evidence link.

  • Claim deadline

    June 30, 2026

    Verified Jun 19, 2026 · against the official settlement website

  • Eligibility summary

    Investors who purchased or otherwise acquired BioXcel Therapeutics Inc. common stock between March 9, 2023, and June 28, 2023

    Verified Jun 19, 2026 · against the official settlement website

  • Proof requirement

    Yes

    Verified Jun 19, 2026 · against the official settlement website

  • Payment status

    Claim period open

    Verified Jun 19, 2026 · against the official settlement website

  • Estimated payout

    Approximately $1.52 per share before deductions from a $9,750,000 settlement fund

    Verified Jun 19, 2026 · against the official settlement website

  • Administrator

    Strategic Claims Services

    Verified Jun 19, 2026 · against the official settlement website

Show all 7 more verified fields
  • Official claim URL

    bioxcelsecuritiessettlement.com

    Verified Jun 19, 2026 · against the official settlement website

  • Objection deadline

    August 5, 2026

    Verified Jun 19, 2026 · against the official settlement website

  • Opt-out deadline

    August 5, 2026

    Verified Jun 19, 2026 · against the official settlement website

  • Class period start

    March 9, 2023

    Verified Jun 19, 2026 · against the official settlement website

  • Class period end

    June 28, 2023

    Verified Jun 19, 2026 · against the official settlement website

  • Court

    United States District Court for the District of Connecticut

    Verified Jun 19, 2026 · against the official settlement website

  • Case name

    Hills et al. v. BioXcel Therapeutics, Inc., et al.

    Verified Jun 19, 2026 · against the official settlement website

    Hills et al. v. BioXcel Therapeutics, Inc., et al.

Common questions

Is the BioXcel Therapeutics $9.75M Class Action settlement legitimate?

Yes — the BioXcel Therapeutics $9.75M Class Action settlement is a real claims process that SettleSignal tracks from its official source. It is administered by Strategic Claims Services. File only through the official settlement website (bioxcelsecuritiessettlement.com); a genuine settlement administrator never charges a fee to file. SettleSignal last checked this record against the official source on June 19, 2026. Always confirm the current details on the official site before filing.

Who may qualify for this settlement?

Investors who purchased or otherwise acquired BioXcel Therapeutics Inc. common stock between March 9, 2023, and June 28, 2023

How much can I get from the BioXcel Therapeutics $9.75M Class Action settlement?

Approximately $1.52 per share before deductions from a $9,750,000 settlement fund. The exact amount you may receive is decided by the settlement administrator based on your valid claim and is not guaranteed; a total settlement-fund figure is shared among all eligible claimants, not paid to each person.

What is the claim deadline?

The claim deadline is June 30, 2026. Confirm the current deadline on the official settlement source before filing.

Do I need proof to claim?

Proof requirement: Yes. The settlement administrator determines what documentation, if any, is required.

What is the current payment status?

Current payment status: Claim period open. Payments are issued by the administrator after the court process concludes.

When will BioXcel Therapeutics $9.75M Class Action Settlement pay out?

Current payment status: Claim period open. Class-action payouts typically begin only after final approval and any appeals. See our payout timeline guide.

Where is the official BioXcel Therapeutics $9.75M Class Action Settlement claim form?

The official claim form is hosted by the settlement administrator, Strategic Claims Services. Use the 'Open official claim form' button on this page — never pay a fee to file.

Where to act

When you are ready, you open the official claim form yourself. SettleSignal does not file claims or determine eligibility.

Claim window closed Track it free

The claim link is hidden because the record is not in an open claim window.

Not ready to file today? Track it free — we'll remind you 30, 14, 7, and 1 day before Jun 30, 2026, and keep your claim details in one place.

Listed on the official settlement website (Strategic Claims Services).

Status history

Every status and verification change we have recorded for this settlement, newest first. We log the date we made each change; we never publish the underlying evidence link.

  1. Claim deadline passed.
  2. Settlement published after verification.
  3. Verified field details updated from an official source.
SettleSignal summary card for BioXcel Therapeutics $9.75M Class Action Settlement — $1.52, claim by June 30, 2026. Checked against the official settlement source on June 19, 2026.
Share this settlement — free to repost with a link back.

Disclaimer

SettleSignal summarizes publicly available settlement information and links to official settlement sources. We are not a law firm, do not provide legal advice, do not submit claims on your behalf, and do not determine eligibility or payout approval. You open the official claim form yourself. Only file a claim if the information you provide is accurate.